Caminati, M.; Guarnieri, G.; Batani, V.; Scarpieri, E.; Finocchiaro, A.; Chieco-Bianchi, F.; Senna, G.; Vianello, A.
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines 2021, 9, 853.
https://doi.org/10.3390/vaccines9080853
AMA Style
Caminati M, Guarnieri G, Batani V, Scarpieri E, Finocchiaro A, Chieco-Bianchi F, Senna G, Vianello A.
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines. 2021; 9(8):853.
https://doi.org/10.3390/vaccines9080853
Chicago/Turabian Style
Caminati, Marco, Gabriella Guarnieri, Veronica Batani, Elena Scarpieri, Anita Finocchiaro, Fulvia Chieco-Bianchi, Gianenrico Senna, and Andrea Vianello.
2021. "COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control" Vaccines 9, no. 8: 853.
https://doi.org/10.3390/vaccines9080853
APA Style
Caminati, M., Guarnieri, G., Batani, V., Scarpieri, E., Finocchiaro, A., Chieco-Bianchi, F., Senna, G., & Vianello, A.
(2021). COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines, 9(8), 853.
https://doi.org/10.3390/vaccines9080853
